IRLAB Therapeutics AB (publ) (IRLAB-A) — Cash Flow Quality Index

Latest as of September 2021: 1.67x

IRLAB Therapeutics AB (publ) (IRLAB-A) has a Cash Flow Quality Index of 1.67x as of September 2021. Operating cash flow of Skr202.83 Million exceeds net income of Skr121.67 Million, indicating high earnings quality where cash backs reported profits. Explore IRLAB-A operating cash flow to assess how effectively this company generates cash.

Cash Flow Quality Index

1.67x
Operating CF / Net Income

Operating Cash Flow

Skr202.83 Million
SEK

Net Income

Skr121.67 Million
SEK

Data as of

Sep 2021
Most recent filing

IRLAB Therapeutics AB (publ) Cash Flow Quality Index (2021–2021)

Historical Cash Flow Quality Index for IRLAB Therapeutics AB (publ) across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check IRLAB-A capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.

Annual Cash Flow Quality Index for IRLAB Therapeutics AB (publ) (2021–2021)

Year-by-year earnings quality comparison for IRLAB Therapeutics AB (publ). For live market cap and the full company financial profile, see IRLAB Therapeutics AB (publ) market capitalisation.

Year Quality Index Operating CF (SEK) Net Income YoY Change
2021 2.45x Skr128.64 Million Skr52.58 Million —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.